Clinical Trial Update: Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome [NA]

View source ↗

Summary

A clinical trial update indicates that the study evaluating the efficacy and safety of Gelsectan for diarrhea-predominant irritable bowel syndrome (IBS-D) is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Gelsectan

Snippet

Sponsor: University Medical Center Ho Chi Minh City (UMC) | Conditions: Diarrhea-predominant Irritable Bowel Syndrome, Irritable Bowel Syndrome of Diarrhea Type (IBS-D) | NA | Status: RECRUITING